Acreage Holdings, Inc.

CNSX:ACRG.A.U Stock Report

Market Cap: US$64.6m

Acreage Holdings Past Earnings Performance

Past criteria checks 0/6

Acreage Holdings's earnings have been declining at an average annual rate of -1.8%, while the Pharmaceuticals industry saw earnings growing at 26.2% annually. Revenues have been growing at an average rate of 36.9% per year.

Key information

-1.8%

Earnings growth rate

4.0%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate36.9%
Return on equityn/a
Net Margin-58.5%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Acreage Holdings, Inc. (CSE:ACRG.A.U) Stock Rockets 44% But Many Are Still Ignoring The Company

Sep 07
Acreage Holdings, Inc. (CSE:ACRG.A.U) Stock Rockets 44% But Many Are Still Ignoring The Company

Investors Still Aren't Entirely Convinced By Acreage Holdings, Inc.'s (CSE:ACRG.A.U) Revenues Despite 44% Price Jump

Sep 07
Investors Still Aren't Entirely Convinced By Acreage Holdings, Inc.'s (CSE:ACRG.A.U) Revenues Despite 44% Price Jump

Acreage Holdings, Inc. (CSE:ACRG.A.U) Just Reported, And Analysts Assigned A US$1.50 Price Target

Aug 10
Acreage Holdings, Inc. (CSE:ACRG.A.U) Just Reported, And Analysts Assigned A US$1.50 Price Target

Revenue & Expenses Breakdown
Beta

How Acreage Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:ACRG.A.U Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23228-133960
30 Jun 23233-1481020
31 Mar 23236-1421050
31 Dec 22237-1401070
30 Sep 22238-851060
30 Jun 22224-751010
31 Mar 22207-681010
31 Dec 21189-63990
30 Sep 21162-601220
30 Jun 21146-881310
31 Mar 21129-1221480
31 Dec 20115-2871860
30 Sep 20104-3001970
30 Jun 2095-2982180
31 Mar 2085-2992280
31 Dec 1974-1502010
30 Sep 1963-1251630
30 Jun 1947-991240
31 Mar 1932-47780
31 Dec 1821-27470
30 Sep 1813-8310
30 Jun 1893170
31 Mar 188-11130
31 Dec 178-9100
31 Dec 164-230

Quality Earnings: ACRG.A.U is currently unprofitable.

Growing Profit Margin: ACRG.A.U is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ACRG.A.U is unprofitable, and losses have increased over the past 5 years at a rate of 1.8% per year.

Accelerating Growth: Unable to compare ACRG.A.U's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ACRG.A.U is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22%).


Return on Equity

High ROE: ACRG.A.U's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.